Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Female superiority.

P Reizenstein

    Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Swedish women experience 10% longer life expectancy than men, with survival rates still rising. This survival advantage is observed across several leukemia types and lymphomas, suggesting potential biological differences in cancer development and treatment response.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of Cytotoxic Cells on Minimal Residual Leukemia.

    Leukemia & lymphoma·2016
    Same author

    Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty.

    Obesity surgery·2000
    Same author

    Blocking of MHC class I antigens on leukemic B-cells enhances their conjugate formation with cytotoxic lymphocytes and their susceptibility to lysis.

    Leukemia & lymphoma·1998
    Same author

    [A study and treatment of a group of patients with electro-hypersensitivity. More than half of the patients were able to return to work].

    Lakartidningen·1996
    Same author

    Leukotrienes and lipoxins--new potential performers in the regulation of human myelopoiesis.

    Leukemia research·1994
    Same author

    The quandary of cancer prevention.

    Journal of clinical epidemiology·1994
    Same journal

    Corrigendum to "Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization" [Biomed. Pharmacother. 141 (2021) 111883].

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Euphol targets key oncogenic processes and promotes chemoprevention in organoid and In Vivo models of colorectal cancers.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    CAR-T cell therapy and oncolytic viruses: A synergic approach for advanced GI cancers.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    See all related articles

    Area of Science:

    • Oncology
    • Epidemiology
    • Sex Differences in Medicine

    Background:

    • Significant disparities exist in life expectancy between genders, with women generally living longer.
    • Cancer survival rates and treatment responses can vary based on sex, necessitating further investigation into underlying biological and environmental factors.

    Purpose of the Study:

    • To analyze sex-based differences in median expected survival in Sweden.
    • To compare prognoses for various hematologic malignancies between men and women.
    • To explore potential sex-based differences in resistance to radiation- or smoking-induced malignant transformation.

    Main Methods:

    • Survival data analysis comparing Swedish men and women.
    • Comparative prognosis analysis for specific hematologic cancers (chronic myelocytic leukemia, acute leukemias, multiple myeloma, malignant lymphoma).

    Related Experiment Videos

  • Review of early indications regarding sex differences in resistance to carcinogens.

    • Main Results:

    • Median expected survival in Swedish women is 10% greater than in men and continues to increase.
    • Male survival rates have plateaued for the past decade.
    • Women demonstrate superior prognoses in chronic myelocytic leukemia, acute leukemias, multiple myeloma, and malignant lymphoma, particularly with immunotherapy.
    • Preliminary evidence suggests women may exhibit greater resistance to malignant transformation induced by radiation and smoking.

    Conclusions:

    • Women in Sweden have a significant and increasing survival advantage over men.
    • Sex-based differences in prognosis are evident across multiple hematologic malignancies, highlighting the importance of immunotherapy in female patients.
    • Potential sex-based differences in susceptibility to environmental carcinogens warrant further research.